Clinical Study

Chronic Gastritis in Dermatitis Herpetiformis: A Controlled Study

Table 2

Gastric and duodenal findings, dapsone, and gluten-free diet (GFD) treatment, and associated diseases and malignancies in 16 dermatitis herpetiformis (DH) patients with chronic atrophic gastritis.

Patient no. Sex/age (years) Year of DH diagnosis Gastric findings Duodenal histology at diagnosis/on GFD Associated autoimmune diseases and malignancies
Corpus atrophy/metaplasia1Antrum atrophy/metaplasia1Helicobacter pylori

1F/5319961/10/0PVABreast cancer 1992
2F/6919991/00/0PVA
3M/6820001/22/2PVA/NGastric cancer 2001
4M/6420013/20/0PVA/N Hypothyreosis >10 yrs before DH diagnosis
Prostate cancer 2010
5M/6120011/00/1N/N
6F/5820011/00/0 + PVA/N
7F/6220012/00/0PVABreast cancer 1992
8M/5720011/00/0 + PVA
9M/4820021/00/0 + N
10M/7120032/10/0N Vitiligo 2003
11F/5620033/10/0PVA/N Pernicious anemia 2004
Graves’ disease 2005
12M/7120042/10/2 + N
13M/7620063/20/1N
14F/7420071/01/0 + PVA
15F/6320071/00/0 + SVA
16M/6920080/0 + SVA

SVA: subtotal villous atrophy, PVA: partial villous atrophy, N: normal mucosa at diagnosis and on a gluten-free diet (GFD).
1score 0–3 according to the Sydney System.